Project Grant K01DA061444
- This federal Project Grant award from the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $370,000.00 to Marshall University Research Corporation (MURC) to determine the impact of synthetic coolants on nicotine's abuse liability and initiation-related behaviors. The research aims to address a critical knowledge gap in understanding the effects of synthetic coolants used in vaping products, as...
- This $515,632 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to prepare the U.S. and states for potential new cigarette product standards that could significantly increase smoking cessation rates. The research team at the University of Minnesota will provide state-specific estimates of the number of people who smoke (PWS) that will quit smoking in response to a menthol ban and nicotine reduction standard, as well as the...
- The Department of Health and Human Services, through the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), awarded a $816,307 project grant to Health Research, Inc. to assess the impact of the substantial equivalence mechanism on the cigarette and cigar markets. The 5-year research project, which commenced on September 15, 2025, aims to characterize the marketplace for cigarette and cigar products that have received substantial equivalence...
- The University of Oklahoma Health Sciences Center (OUHSC) was awarded a $1,197,896 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077). The objective of this 5-year longitudinal study is to use real-time ecological momentary assessment (EMA) methods to better understand the impact of electronic nicotine delivery system (ENDS) product characteristics, such as...
- The federal Project Grant award titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit" is funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $663,554.00 with an award date of August 18, 2025 and an ultimate completion date of July 31, 2030. The grant supports research to explore the use of harm reduction product sampling, such as e-cigarettes, heated tobacco products, and oral...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $885,824 aims to assess consumer response to smokeless tobacco modified risk marketing orders. The research activities will explore 1) consumers' exposure and reactions to authorized smokeless tobacco modified risk tobacco product (MRTP) claims, and 2) whether the MRTP claims influence smokeless tobacco demand and sensory evaluations. The project will be conducted...
- This Project Grant award, funded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research on the "Addiction Potential, Flavoring Content, and Substitutability of Concept Flavored Cigarillos." The $752,701 award, with a performance period from August 1, 2025 to May 31, 2030, will be conducted by the University of Oklahoma Health Sciences Center (OUHSC). The research aims to investigate the addiction...
- This federal Project Grant award in the amount of $403,689 was provided by the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), to Rutgers, The State University of New Jersey. The purpose of the grant is to investigate the influence of menthol cigarette smoking on lung cancer screening eligibility in a national prospective study. The award period runs from August 1, 2025 through July 31, 2027. Rutgers will conduct comprehensive research to...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 (Trans-NIH Research Support) is supporting a $675,599 study titled "Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale". The primary awardee is Rutgers, The State University of New Jersey, who will collaborate with Columbia University on the project. The study aims to: 1) characterize the implementation and reach of...
- This Project Grant award, valued at $282,862 and awarded by the National Science Foundation (NSF) under the Integrative Activities program (CFDA 47.083), supports research at Oklahoma State University (OSU) to investigate the health risks of e-cigarettes and cannabis aerosols, particularly those containing unregulated synthetic cooling agents. The key objectives of this 2-year project are to: (1) quantify exposure and toxicity levels of various vaping aerosol components, (2) assess variability...
This Project Grant award of $186,281.00 from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports a study to examine the abuse liability and substitutability of synthetic coolants versus menthol in cigarettes. The study aims to provide critical evidence to inform the FDA's regulatory approach to tobacco products, including understanding the public health implications of emerging nicotine delivery systems. The 5-year project, awarded to The Ohio State University, will employ both laboratory and naturalistic experiments with 40 adult menthol cigarette smokers to assess the subjective effects and substitutability of menthol cigarettes, non-menthol cigarettes with synthetic coolants, and non-menthol control cigarettes. The findings are expected to yield valuable insights for tobacco regulatory science and help mitigate the potential public health impact of synthetic coolant additives in cigarettes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/28/25 | ||
| Not listed | $186.3k | 7/28/25 |